Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Melzer

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
BMC Complementary Medicine and Therapies|October 2, 2025
Interest in complementary and alternative medicine among participants in a study on cancer prevention by green tea extract - results from an expert-based survey of MIRACLE trial participantsAnna Melzer, Niklas Sturm, Friederike Rohlmann, et al.
Scientific Reports|November 3, 2025
Crew resource management and threat and error management improve team communication in endoscopy: a prospective studyDominik Schweikart, Anna Melzer, Niklas Sturm, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|August 26, 2025
Ivosidenib for IDH1-Mutant Intrahepatic Cholangiocarcinoma: Insights From a Multicenter Real-World StudyMonica Niger, Margherita Rimini, Florian Castet, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
BMC Complementary Medicine and Therapies|October 2, 2025
Interest in complementary and alternative medicine among participants in a study on cancer prevention by green tea extract - results from an expert-based survey of MIRACLE trial participantsAnna Melzer, Niklas Sturm, Friederike Rohlmann, et al.
Scientific Reports|November 3, 2025
Crew resource management and threat and error management improve team communication in endoscopy: a prospective studyDominik Schweikart, Anna Melzer, Niklas Sturm, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|August 26, 2025
Ivosidenib for IDH1-Mutant Intrahepatic Cholangiocarcinoma: Insights From a Multicenter Real-World StudyMonica Niger, Margherita Rimini, Florian Castet, et al.
Pageof 1